LY3478045

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3478045, covering 2024-07-25 to 2024-07-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3478045 in Healthy Participants [Phase 1]